Effect of silk fibroin nanofibers containing silver sulfadiazine on wound healing

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 5277-5287

  Jeong, Lim ^a   Kim, Min Hee ^a   Jung, Ju Young ^b   Min, Byung Moo ^c   Park, Won Ho ^a  

^a Department of Advanced Organic Materials and Textile System Engineering ^*  (South Korea)

^b Chungnam National University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Nanofibrous matrix; Silk fibroin; Silver sulfadiazine; Wound healing

Indexed keywords

NANOFIBER; SILK FIBROIN NANOFIBER; SULFADIAZINE SILVER; UNCLASSIFIED DRUG; FIBROIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL ADHESION; CELL COUNT; CELL SPREADING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ELECTROSPINNING; EPIDERMIS CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; NONHUMAN; RAT; RAT MODEL; SILVER DRESSING; WOUND DRESSING; WOUND HEALING; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; INJURIES; SKIN; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CELL ADHESION; CELLS, CULTURED; FIBROBLASTS; FIBROINS; HUMANS; KERATINOCYTES; MALE; NANOFIBERS; RATS; RATS, SPRAGUE-DAWLEY; SILVER SULFADIAZINE; SKIN; WOUND HEALING;

EID: 84924787985     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S71295     Document Type: Article

References (31)

1. Klasen HJ. A historical review of the use of silver in the treatment of burns. I. Early uses. Burns. 2000;26(2):117-130.
2. Moyer CA, Brentano L, Gravens DL, Margraf HW, Monafo WW. Treatment of large human burns with 0.5 percent silver nitrate solution. Arch Surg. 1965;90(6):812–867.
3. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns. 2000;26(2):131-138.
4. Bellinger CG, Conway H. Effect of silver nitrate and sulfamylon on epithelial regeneration. Plast Reconstr Surg. 1970;45:582-585.
5. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76-83.
6. Stanford W, Rappole BW, Fox CL. Clinical experience with silver sulfadiazine, a new topical agent for control of Pseudomonas infections in burns. J Trauma. 1969;9(5):377-388.
7. Fox CL, Modak SM. Mechanism of silver sulfadiazine action on burn wound infection. Antimicrob Agents Chemother. 1974;5(6):582-588.
8. Burd A, Kwok CH, Hung SC, et al. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal model. Wound Repair Regen. 2007;15(1):94-104.
9. Lok CN, Ho CM, Chen R, et al. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res. 2006;5(4):916-924.
10. Lansdown AB. A guide to the properties and uses of silver dressings in wound care. Prof Nurse. 2005;20(5):41-43.
11. Dunn K, Edwards-Jones V. The role of Acticoat with nanocrystalline silver in the management of burns. Burns. 2004;30 Suppl 1:S1-S9.
12. Yu DG, Zhou J, Chatterton NP, et al. Polyacrylonitrile nanofibers coated with silver nanoparticles using a modified coaxial electrospinning process. Int J Nanomedicine. 2012;7:5725-5732.
13. Draelos ZD. The cosmeceutical realm. Clin Dermatol. 2008;26(6): 627-632.
14. Vepari C, Kaplan DL. Silk as a biomaterial. Prog Polym Sci. 2007; 32(8-9):991-1007.
15. Kasoju N, Bora U. Silk fibroin in tissue engineering. Adv Healthc Mater. 2012;1(4):393-412.
16. Yan S, Zhang Q, Wang J, et al. Silk fibroin/chondroitin sulfate/ hyaluronic acid ternary scaffolds for dermal tissue reconstruction. Acta Biomater. 2013;9(3):6771-6782.
17. Kundu B, Rajkhowa R, Kundu SC, et al. Silk fibroin biomaterials for tissue regenerations. Adv Drug Deliv Rev. 2013;65(4):457-470.
18. Min BM, Lee G, Kim SH, et al. Electrospinning of silk fibroin nano fibers and its effects on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials. 2004;25(7-8):1289-1297.
19. Jeong L, Yeo I, Kim HN, et al. Plasma-treated silk fibroin nanofibers for skin regeneration. Int J Biol Macromol. 2009;44(3):222-228.
20. Mould AP, Askari JA, Humphries MJ. Molecular basis of ligand recognition by integrin alpha 5beta 1. I. Specificity of ligand binding is determined by amino acid sequences in the second and third NH2-terminal repeats of the alpha subunit. J Biol Chem. 2000;275(27):20324-20336.
21. Chun JY, Kang HK, Jeong L, et al. Epidermal cellular response to poly(vinyl alcohol) nanofibers containing silver nanoparticles. Colloids Surf B Biointerfaces. 2010;78(2):334-342.
22. Martin P. Wound healing-aiming for perfect skin regeneration. Science. 1997;276(5309):75-81.
23. Nagato H, Umebayashi Y, Wako M, Tabata Y, Manabe M. Collagenpoly glycolic acid hybrid matrix with basic fibroblast growth factor accelerates angiogenesis and granulation tissue formation in diabetic mice. J Dermatol. 2006;33(10):670-675.
24. Jester JV, Petroll WM, Cavanagh HD. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res. 1999;18(3):311-356.
25. Feugate JE, Li Q, Wong L, Martin-Green M. The cxc chemokine cCAF stimulates differentiation of fibroblasts into myofibroblasts and accelerates wound closure. J Cell Biol. 2002;156(1):161-172.
26. Liu X, Lee PY, Ho CM, et al. Silver nanoparticles mediate differential reponses in keratinocytes and fibroblasts during skin wound healing. ChemMedChem. 2010;5(3):468-475.
27. Rustogi R, Milm J, Frazer JF, Kimble RM. The use of Acticoat in neonatal burns. Burns. 2005;31(7):878-882.
28. Demling RH, DeSanti MDL. The role of silver technology in wound healing: Part 1: Effects of silver on wound management. Wounds. 2001;13 Suppl A:4-15.
29. Kunimoto BT. Management and prevention of venous leg ulcers: a literature-guided approach. Ostomy Wound Manag. 2001;47(5): 38-53.
30. Demling RH, DeSanti MDL. The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver. Burns. 2002;28(3):264-266.
31. Moiemen NS, Shale E, Drysdale KJ, et al. Acticoat dressings and major burns: systemic silver absorption. Burns. 2011;37(1):27-35.